ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,266, issued on May 26, was assigned to Rivo Bio Inc. (Boston).
"Indane-, indene-, azaindane-, and azaindene-amines as activators of serotonin receptors" was invented by Alan C. Gibbs (Wyndmoor, Pa.) and Rebecca Aron (Brookline, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel chemical compounds of indane-, indene-, azaindane-, and azaindene-amines that act as 5-HT2A receptor agonists. These compounds are designed to offer improved therapeutic profiles for the treatment of a variety of neuropsychiatric, neurological, and neurodegenerative disorders. Also disclosed are methods for the synthesis and pharmaceuti...